<DOC>
	<DOCNO>NCT00001397</DOCNO>
	<brief_summary>This study design allow evaluation , follow-up , medical care patient blood disorder currently participate research study conduct Hematology Branch National Heart , Lung Blood Institute ( NHLBI ) screen participation study . The purpose study allow investigation blood disorder patient order teach , learn , gather information disease blood . In addition , study allow researcher opportunity evaluate patient refer Hematology Branch NHLBI rare undiagnosed disease blood . This may potentially beneficial patient time contribute development new research idea .</brief_summary>
	<brief_title>Evaluation , Treatment , Training Patients With Blood Disorders</brief_title>
	<detailed_description>This protocol design allow evaluation , follow , standard medical care patient ( appropriate , stem cell donor ) bone marrow failure state , cytopenia , metastatic solid tumor , hematologic malignancy currently enter active NHLBI Hematology Branch protocol screen active NHLBI research protocol . Its purpose allow investigation hematologic problem patient primary purpose teach further general hematologic knowledge . The ability evaluate treat patient wide variety hematologic disease critical maintaining accreditation hematology fellowship program training fellows competent hematologist , well keep staff , include senior staff , up-to-date familiar evaluation treatment patient wide spectrum hematologic disease . It also allow Hematology Branch evaluate patient refer rare yet undiagnosed hematologic problem , potentially benefit patient stimulate new research direction Hematology Branch future . Periodic follow-up treatment patient previously enter Hematology Branch protocols order monitor long-term course underlie hematologic state consequence experimental treatment also require fellowship training , maintenance good referral relationship patient physician .</detailed_description>
	<mesh_term>Hematologic Diseases</mesh_term>
	<mesh_term>Hematologic Neoplasms</mesh_term>
	<mesh_term>Pancytopenia</mesh_term>
	<criteria>INCLUSION CRITERIA : Patients ( appropriate patient 's stem cell donor ) may enter protocol discretion Principal and/or Associate Investigators : An investigator decide best interest patient/donor Branch patient enrol protocol await decision eligibility protocol ; enrollment another protocol , allow careful evaluation patient unique rare disorder direct interest Branch ; common disorder fellowship teach purpose . The patient patient 's guardian capable inform consent sign consent form . The consent form sign parent guardian patient age 18 . Age great equal 2 weight great 12 kg .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 10, 2016</verification_date>
	<keyword>Hematologic Malignancies</keyword>
</DOC>